170 related articles for article (PubMed ID: 31248172)
1. Genome-Guided Discovery of Pretilactam from
Wang J; Hu X; Sun G; Li L; Jiang B; Li S; Bai L; Liu H; Yu L; Wu L
Molecules; 2019 Jun; 24(12):. PubMed ID: 31248172
[No Abstract] [Full Text] [Related]
2. Complete Genome Sequence of Actinosynnema pretiosum X47, An Industrial Strain that Produces the Antibiotic Ansamitocin AP-3.
Zhong C; Zong G; Qian S; Liu M; Fu J; Zhang P; Li J; Cao G
Curr Microbiol; 2019 Aug; 76(8):954-958. PubMed ID: 29858620
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic change and pathway profiling reveal enhanced ansamitocin P-3 production in Actinosynnema pretiosum with low organic nitrogen availability in culture medium.
Liu T; Yang L; Chen J; Hu F; Wei LJ; Hua Q
Appl Microbiol Biotechnol; 2020 Apr; 104(8):3555-3568. PubMed ID: 32114676
[TBL] [Abstract][Full Text] [Related]
4. Effects of the Methylmalonyl-CoA Metabolic Pathway on Ansamitocin Production in Actinosynnema pretiosum.
Zhao M; Fan Y; Wei L; Hu F; Hua Q
Appl Biochem Biotechnol; 2017 Mar; 181(3):1167-1178. PubMed ID: 27787765
[TBL] [Abstract][Full Text] [Related]
5. Increased yield of AP-3 by inactivation of asm25 in Actinosynnema pretiosum ssp. auranticum ATCC 31565.
Cheng H; Xiong G; Li Y; Zhu J; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Liu G; Chen H
PLoS One; 2022; 17(3):e0265517. PubMed ID: 35316825
[TBL] [Abstract][Full Text] [Related]
6. Identification and Engineering of Post-PKS Modification Bottlenecks for Ansamitocin P-3 Titer Improvement in Actinosynnema pretiosum subsp. pretiosum ATCC 31280.
Ning X; Wang X; Wu Y; Kang Q; Bai L
Biotechnol J; 2017 Nov; 12(11):. PubMed ID: 28881098
[TBL] [Abstract][Full Text] [Related]
7. Genome-Scale Metabolic Model of
Li J; Sun R; Ning X; Wang X; Wang Z
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30036981
[No Abstract] [Full Text] [Related]
8. Process optimization with alternative carbon sources and modulation of secondary metabolism for enhanced ansamitocin P-3 production in Actinosynnema pretiosum.
Fan Y; Gao Y; Zhou J; Wei L; Chen J; Hua Q
J Biotechnol; 2014 Dec; 192 Pt A():1-10. PubMed ID: 25456055
[TBL] [Abstract][Full Text] [Related]
9. Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams against Trypanosoma brucei.
Schulze CJ; Donia MS; Siqueira-Neto JL; Ray D; Raskatov JA; Green RE; McKerrow JH; Fischbach MA; Linington RG
ACS Chem Biol; 2015 Oct; 10(10):2373-81. PubMed ID: 26270237
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics analysis of Actinosynnema pretiosum with improved AP-3 production by enhancing UDP-glucose biosynthesis.
Liu T; Jin Z; Wang Z; Chen J; Wei LJ; Hua Q
J Biosci Bioeng; 2020 Jul; 130(1):36-47. PubMed ID: 32179024
[TBL] [Abstract][Full Text] [Related]
11. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica.
Udwary DW; Zeigler L; Asolkar RN; Singan V; Lapidus A; Fenical W; Jensen PR; Moore BS
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10376-81. PubMed ID: 17563368
[TBL] [Abstract][Full Text] [Related]
12. Mirilactams C-E, Novel Polycyclic Macrolactams Isolated from Combined-Culture of Actinosynnema mirum NBRC 14064 and Mycolic Acid-Containing Bacterium.
Hoshino S; Ozeki M; Wong CP; Zhang H; Hayashi F; Awakawa T; Morita H; Onaka H; Abe I
Chem Pharm Bull (Tokyo); 2018; 66(6):660-667. PubMed ID: 29863068
[TBL] [Abstract][Full Text] [Related]
13. Constitutive overexpression of asm18 increases the production and diversity of maytansinoids in Actinosynnema pretiosum.
Li S; Lu C; Chang X; Shen Y
Appl Microbiol Biotechnol; 2016 Mar; 100(6):2641-9. PubMed ID: 26572523
[TBL] [Abstract][Full Text] [Related]
14.
Hu X; Li X; Sheng Y; Wang H; Li X; Ou Y; Deng Z; Bai L; Kang Q
Molecules; 2020 Sep; 25(18):. PubMed ID: 32932689
[No Abstract] [Full Text] [Related]
15. Enhancement of UDPG synthetic pathway improves ansamitocin production in Actinosynnem pretiosum.
Fan Y; Zhao M; Wei L; Hu F; Imanaka T; Bai L; Hua Q
Appl Microbiol Biotechnol; 2016 Mar; 100(6):2651-62. PubMed ID: 26585444
[TBL] [Abstract][Full Text] [Related]
16. The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum.
Yu TW; Bai L; Clade D; Hoffmann D; Toelzer S; Trinh KQ; Xu J; Moss SJ; Leistner E; Floss HG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7968-73. PubMed ID: 12060743
[TBL] [Abstract][Full Text] [Related]
17. Asm8, a specific LAL-type activator of 3-amino-5-hydroxybenzoate biosynthesis in ansamitocin production.
Pan W; Kang Q; Wang L; Bai L; Deng Z
Sci China Life Sci; 2013 Jul; 56(7):601-8. PubMed ID: 23832249
[TBL] [Abstract][Full Text] [Related]
18. Improved AP-3 production through combined ARTP mutagenesis, fermentation optimization, and subsequent genome shuffling.
Li J; Guo S; Hua Q; Hu F
Biotechnol Lett; 2021 Jun; 43(6):1143-1154. PubMed ID: 33751317
[TBL] [Abstract][Full Text] [Related]
19. Proteomic studies on anti-tumor agent ansamitocin P-3 producer Actinosynnema pretiosum in response to ammonium and isobutanol.
Lin J; Zhong JJ
Bioprocess Biosyst Eng; 2017 Jul; 40(7):1133-1139. PubMed ID: 28382459
[TBL] [Abstract][Full Text] [Related]
20. Rational approach to improve ansamitocin P-3 production by integrating pathway engineering and substrate feeding in Actinosynnema pretiosum.
Du ZQ; Zhong JJ
Biotechnol Bioeng; 2018 Oct; 115(10):2456-2466. PubMed ID: 29940067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
